Polifarma is Once Again on the ISO Top 500 List

According to the results of the Istanbul Chamber of Industry's 2023 Turkey’s Top 500 Industrial Enterprises Research, we are proud to have risen 103 positions this year and secured a place in the ISO Top 500 List.

The research conducted by the Istanbul Chamber of Industry, based on net sales from production, has been announced. For 38 years, Polifarma, one of Turkey’s pioneering organizations in the healthcare sector with 100% local capital, has been making valuable contributions to public health and the healthcare industry. This year, Polifarma has once again been listed among Turkey’s Top 500 Industrial Enterprises, climbing to the 345th position.

Since our establishment, we have believed that health is a fundamental human right. By embracing quality, reliability, and innovation, and with our extensive product range, we aim to reduce Turkey’s dependency on imports and ensure easy access to medicines. Through our commitment to R&D and our investments, we continue to strengthen and advance every day.

Polifarma is Once Again on the ISO Top 500 List

According to the results of the Istanbul Chamber of Industry's 2023 Turkey’s Top 500 Industrial Enterprises Research, we are proud to have risen 103 positions this year and secured a place in the ISO Top 500 List.

The research conducted by the Istanbul Chamber of Industry, based on net sales from production, has been announced. For 38 years, Polifarma, one of Turkey’s pioneering organizations in the healthcare sector with 100% local capital, has been making valuable contributions to public health and the healthcare industry. This year, Polifarma has once again been listed among Turkey’s Top 500 Industrial Enterprises, climbing to the 345th position.

Since our establishment, we have believed that health is a fundamental human right. By embracing quality, reliability, and innovation, and with our extensive product range, we aim to reduce Turkey’s dependency on imports and ensure easy access to medicines. Through our commitment to R&D and our investments, we continue to strengthen and advance every day.